Business & Regulation

Sitting Down With… Richard Markus, Vice President of Global Development, Amgen, USA

Can we predict the impact Brexit will have on UK life sciences?

A Spotlight Interview with... Kishor Wasan, Dean of the College of Pharmacy and Nutrition, University of Saskatchewan, Canada.

The US regulatory agency has enlisted other authorities in Europe to carry out inspections.

Iraq war victims accuse several pharma companies of aiding and abetting a terrorist group.

Sitting Down With… Margaret Hamburg, President-elect AAAS, Foreign secretary of National Academy of Medicine

Pharma’s 2022 growth forecast has been reduced for the first time in a decade.

EMA relocation, a price-fixing scandal, and FDA warning letters… What's new for pharma in business?

The EFPIA highlights the risks of disrupting UK–EU medicine supply chains.

Researchers find significant variation in regulation of pharmaceutical market systems in the developing world